...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Phase 1b/2 trial expected to initiate 1Q 2019

managed to transfer from my RRSP to my TFSA by transferring RRSP to non registered acct and then into TFSA . Have been trying to get it done for over a year.

Share
New Message
Please login to post a reply